Stephen FO: The case for a name change from neoadjuvant to induction chemotherapy. Cancer 63: 1245-1246, 1989.
Fujii M: Using preoperative UFT to predict sensitivity to fluoropyrimidine in colorectal cancer. Oncology 17: 55-60, 1999.
Ott K, Weber W and Siewert JR: The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19: 433-442, 2006.
Sasako M, Sano T, Yamamoto S, et al: Randomized phase III trial of standard D2 versus D2+para-aortic lymph node dissection for clinically M0 advanced gastric cancer: JCOG 9501. Proc ASCO (abstr #4015), 2006.
Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1): 202-206, 2006.